微创医疗(00853.HK) 公布，全资附属公司上海默化与配售代理订立大宗交易协议，拟出售所持的最多3,016.35万股微创机器人(02252.HK) 股份，占微创机器人全部已发行股本的约3%，销售价每股15.5元，较其昨日(13日)收市价价17.98元折让约13.79%，预期所得款项净额将达到约4.58亿元，将用作一般营运资金。
另外，微创机器人亦计划配售2,513.65万股新H股，占扩大后股本约2.44%，惟售事项及配售事项并非互为条件。预期销售事项及配售事项各自的交割不会同时进行。
于股份销售及配售完成后，假设所有销售股份及配售股份均获成功配售，微创医疗所持有的微创机器人已发行股本将由约48.08%摊薄至约43.98%，连同上海默化的一致行动人士上海擎祯企业管理咨询中心(有限合伙)所持有的1.64%的股权，集团于微创机器人的权益料达到45.63%。(gc/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-05-13 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.